Join to View Full Profile
6701 Fannin St.Suite 1400Houston, TX 77030
Phone+1 832-824-1471
Dr. Whittle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarah Whittle is a Pediatric Hematologist and Oncologist based in Houston, Texas. She is an Associate Professor of Pediatrics at Baylor College of Medicine. She completed her Pediatrics residency at Brown University from 2009 to 2012 and her Pediatric Hematology/Oncology fellowship at Baylor College of Medicine from 2012 to 2015. Additionally, she holds a Master's degree in Clinical Investigation from Baylor College of Medicine. Her specific area of expertise is pediatric bone and soft tissue sarcomas and she actively contributes to the field through publications and overseeing clinical trials.
Education & Training
Baylor College of MedicineMS, Clinical investigation, 2014 - 2016
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Brown UniversityResidency, Pediatrics, 2009 - 2012
Geisel School of Medicine at DartmouthClass of 2009
Certifications & Licensure
TX State Medical License 2015 - 2026
PA State Medical License 2012 - 2012
RI State Medical License 2009 - 2012
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- IC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
- TAA-Specific CTLS for Solid Tumors (TACTASOM) Start of enrollment: 2015 Apr 01
- High-Risk Neuroblastoma Chemotherapy Without G-CSF Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 1 citationsLenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial.Nathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, Quentin Campbell-Hewson, Filemon S Dela Cruz
JAMA Oncology. 2024-12-01 - 2 citationsProlonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.Anne Miller, Rachel Daum, Tao Wang, Mengfen Wu, Candise Tat
Cytotherapy. 2024-09-01 - 30 citationsAn international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.David S Shulman, Sarah B Whittle, Didier Surdez, Kelly M Bailey, Enrique de Álava
NPJ Precision Oncology. 2022-09-17
Press Mentions
- Iterion Therapeutics Announces Initiation of Phase 1/2 Clinical Trial to Study Tegavivint in Pediatric CancersNovember 9th, 2021
- Iterion Therapeutics Announces Initiation of Phase 1/2 Clinical Trial to Study Tegavivint in Pediatric CancersNovember 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
